[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
12-Jun-2014

[ | E-mail ] Share Share

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University
www.twitter.com/IUBloomington

Two Regenstrief investigators receive NIH career development awards

IMAGE: Michael LaMantia, MD, MPH is a Regenstrief Institute investigator and an Indiana University Center for Aging Research scientist.

Click here for more information.

INDIANAPOLIS -- Two Regenstrief Institute investigators and Indiana University Center for Aging Research scientists -- Michael LaMantia, M.D., MPH, and Noll L. Campbell, PharmD -- have each received five-year Mentored Patient-Oriented Research Career Development K23 Awards from the National Institute on Aging at the National Institutes of Health.

Dr. LaMantia is an assistant professor of medicine at the IU School of Medicine. His K23 award supports a project titled "DEEDS: Delirium Evaluation in the Emergency Department for Seniors."

Delirium affects approximately 10 percent of older adults who seek care in the emergency department, yet it is unrecognized in the majority of cases. To improve the care and management of older adults with delirium, it is critical to understand the dynamics that affect delirium recognition by emergency service providers. The goal of Dr. LaMantia's research is to determine the factors that influence delirium recognition and to discern those approaches to delirium assessment that are most associated with its identification. Dr. LaMantia reviewed the problem in a study published earlier this year in the Annals of Emergency Medicine.

Dr. Campbell is a research assistant professor in the Purdue University College of Pharmacy and a clinical pharmacy specialist in geriatrics with Eskenazi Health. His K23 career development award supports a project titled "Evaluating the Adverse Cognitive Effects of Medications."

IMAGE: Noll L. Campbell, PharmD is a Regenstrief Institute investigator and and Indiana University Center for Aging Research scientist.

Click here for more information.

This work continues his research into the role common medications play on cognition in older adults. A 2013 study by Dr. Campbell found that using anticholinergics -- which block the neurotransmitter acetylcholine -- for as few as 60 days causes memory problems in older adults. This award will further investigate the impact anticholinergics have on cognition and will also study the impact of statins and antihistamines.

###

The Regenstrief Institute is a distinguished medical research organization dedicated to improving the quality and effectiveness of health care. The institute is the home of internationally recognized centers of excellence in aging, biomedical and public health informatics, and health services and health systems research. Institute investigators are faculty members of the Indiana University School of Medicine, other schools at Indiana University-Purdue University Indianapolis, or Purdue University.



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.